PATENT CLAIM ANALYSIS

Application Number: 15870233
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["514", "009700"]

Abstract:
The present invention provides, among other things, methods and compositions for treating brain conditions. In some embodiments, the methods include administering to a subject suffering from or susceptible to a brain condition an angiotensin (1-7) peptide via either an intravenous or subcutaneous route of administration.

Claim (Index 30):
A method of treating stroke comprising\n administering to a subject suffering from stroke an angiotensin (1-7) peptide comprising the amino acid sequence Asp 1 -Arg 2 -Val 3 -Tyr 4 -Ile 5 -His 6 -Pro 7  (SEQ ID NO: 1) via systemic administration, wherein the systemic administration is not intracerebroventricular administration, and wherein the angiotensin (1-7) peptide is administered without the use of modified stem cells.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 86.0
- Lexical Diversity: 1.2093
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13897051', '13752202', '14549096', '13757475', '14506489']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7604450730683492
- 35 USC 102 Novelty (BERT): 0.6299026832259632
- Combined Prediction Score: 0.7473908340841107
- Mean Citation Score: 432.531282
- Max Citation Score: 557.58606
- Similarity Product: 555.9111298646415

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test